Aveanna Healthcare (NASDAQ:AVAH) Posts Earnings Results

Aveanna Healthcare (NASDAQ:AVAH) posted its quarterly earnings data on Thursday. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05, FiscalAI reports. The company had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.

Here are the key takeaways from Aveanna Healthcare’s conference call:

• Q2 revenue rose 13.7% to $670.5 million, while adjusted EBITDA increased 8% to $95.4 million, with year-over-year growth across all three operating segments.
• Aveanna raised 2026 guidance to revenue above $2.68 billion and adjusted EBITDA above $365 million, attributing the increase to core organic performance rather than the recently acquired Family First business.
• The company reported progress on reimbursement and payer initiatives, including seven state rate increases, 37 Private Duty Services preferred payer agreements, and a significant California pediatric nursing rate increase scheduled for January 2027. Aveanna also lifted its long-term organic growth targets for Private Duty Services to 5%–6% and Home Health and Hospice to 8%–10%.
• Management expects gross-margin percentages to remain broadly stable because reimbursement gains will largely be passed through to caregiver wages; it plans to raise California wages ahead of the January 2027 rate increase, creating potential near-term margin pressure. The company also remains highly leveraged, with approximately $1.48 billion of variable-rate debt, despite targeting leverage below 3x over time.

Aveanna Healthcare Trading Up 16.6%

AVAH traded up $1.50 on Thursday, hitting $10.55. The company had a trading volume of 4,582,757 shares, compared to its average volume of 1,613,173. The company has a market cap of $2.30 billion, a PE ratio of 8.93, a PEG ratio of 0.89 and a beta of 1.90. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The business’s fifty day simple moving average is $8.77 and its 200 day simple moving average is $7.71. Aveanna Healthcare has a 12-month low of $5.93 and a 12-month high of $10.91.

Insider Activity

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 125,000 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total transaction of $948,750.00. Following the transaction, the insider owned 212,755 shares in the company, valued at $1,614,810.45. The trade was a 37.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, major shareholder Paul R. Vigano sold 7,000,000 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the transaction, the insider owned 252,899 shares in the company, valued at $1,578,089.76. The trade was a 96.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 31,305,664 shares of company stock valued at $215,555,910 over the last ninety days. 5.30% of the stock is owned by corporate insiders.

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently modified their holdings of AVAH. Invesco Ltd. increased its stake in shares of Aveanna Healthcare by 1,001.5% during the fourth quarter. Invesco Ltd. now owns 360,464 shares of the company’s stock valued at $2,945,000 after buying an additional 327,738 shares during the period. Mackenzie Financial Corp grew its position in shares of Aveanna Healthcare by 12.7% in the 4th quarter. Mackenzie Financial Corp now owns 216,200 shares of the company’s stock worth $1,810,000 after buying an additional 24,447 shares during the last quarter. Zimmer Partners LP purchased a new position in Aveanna Healthcare in the fourth quarter worth $6,189,000. Voloridge Investment Management LLC purchased a new stake in shares of Aveanna Healthcare during the fourth quarter worth about $1,915,000. Finally, Millennium Management LLC boosted its stake in Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after purchasing an additional 1,014,030 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AVAH shares. Truist Financial lifted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a research report on Wednesday, June 3rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Finally, Barclays boosted their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $10.78.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. Aveanna reported adjusted earnings of $0.22 per share, above the $0.17 analyst consensus and up from $0.18 a year earlier. Revenue rose 13.7% year over year to $670.5 million, surpassing estimates of approximately $638.6 million. Aveanna Healthcare Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Profitability improved materially. Second-quarter net income increased to $40.3 million from $27.0 million in the prior-year period, while adjusted EBITDA grew 8.0% to $95.4 million. The company reported a 10.37% net margin and 124.68% return on equity. Aveanna Healthcare Announces Second Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: Full-year guidance was raised. Aveanna increased 2026 revenue guidance to more than $2.68 billion, from $2.63 billion to $2.65 billion previously. Adjusted EBITDA guidance was raised to above $365 million, versus the prior range of $338 million to $342 million. The upgrades suggest management sees continued momentum in its home-care operations. Aveanna Healthcare Revised 2026 Guidance
• Neutral Sentiment: Separate coverage is examining the quarter’s operating metrics against Wall Street estimates and year-ago results. The company’s FY 2026 EPS guidance entry did not provide a usable figure, limiting the earnings outlook to revenue and adjusted EBITDA. Aveanna Q2 Earnings Key Metrics
• Neutral Sentiment: Reported short interest was listed at zero shares, offering no meaningful indication of bearish positioning or potential short-covering demand.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.